BIOCHEMICAL AND PHARMACOLOGICAL EFFECTS OF THE FERMENTATION-DERIVED ANTI-TUMOR AGENT, (ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (AT-125)

被引：0

作者：

NEIL, GL ^{[1
]}

BERGER, AE ^{[1
]}

MCPARTLAND, RP ^{[1
]}

GRINDEY, GB ^{[1
]}

BLOCH, A ^{[1
]}

机构：

[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,CTR CANC DRUG,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263

来源：

CANCER RESEARCH | 1979年 / 39卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：852 / 856

页数：5

共 33 条

[21] EFFECT OF L-(ALPHA-S,5S)-ALPHA-AMINO-3-DHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID ON URINARY-EXCRETION OF METHYLMERCURY IN THE MOUSE
MULDER, KM
KOSTYNIAK, PJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 234 (01): : 156 - 160
[22] L-[ALPHA,S 5S]-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (NSC-163501) - NEW ANTITUMOR ANTIBIOTIC WITH PROPERTIES OF AN ANTAGONIST OF L-GLUTAMINE
JAYARAM, HN
COONEY, DA
BONO, VH
NEAL, G
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 73 - 73
[23] BIOCHEMICAL-MECHANISMS FOR THE SCHEDULED SYNERGISM OF ACIVICIN, L-(S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID AND 5-FLUOROURACIL IN P388 LEUKEMIA
ARDALAN, B
CHANDRASEKARAN, B
STOLINSKY, D
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 270 - 270
[24] INHIBITION OF CELL-CYCLE PROGRESSION OF HUMAN PANCREATIC-CARCINOMA CELLS-INVITRO BY L-(ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID, ACIVICIN (NSC-163501)
MECK, RA
CLUBB, KJ
ALLEN, LM
YUNIS, AA
CANCER RESEARCH, 1981, 41 (11) : 4547 - 4553
[25] NEW ANTITUMOR ANTIMETABOLITE, (ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (NSC-163501) - ANTIMICROBIAL REVERSAL STUDIES AND PRELIMINARY EVALUATION AGAINST L1210 MOUSE LEUKEMIA IN-VIVO
HANKA, LJ
MARTIN, DG
NEIL, GL
CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (02): : 141 - 148
[26] COLLATERAL SENSITIVITY TO N-(PHOSPHONACETYL)-L-ASPARTIC ACID IN A LINE OF P388 LEUKEMIA-CELLS SELECTED FOR RESISTANCE TO L-(ALPHA-S,5S)-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (ACIVICIN)
ARDALAN, B
JAYARAM, HN
JOHNSON, RK
CANCER RESEARCH, 1983, 43 (04) : 1598 - 1601
[27] NEW ANTITUMOR AGENT, (ALPHA-S,4S,5R)-ALPHA-AMINO-3-CHLORO-4-HYDROXY-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (NSC-176324) - PRELIMINARY EVALUATION AGAINST L1210 MOUSE LEUKEMIA INVIVO
MARTIN, DG
HANKA, LJ
NEIL, GL
CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (06): : 935 - 937
[28] L-GLUTAMINE ANTAGONIST PROPERTIES OF ALPHAS, 5S-ALPHA-AMINO-3-CHLORO-4,5-DIHYDRO-5-ISOXAZOLEACETIC ACID (U-42, 126, NSC-163501) IN L1210 CELLS
NEIL, GL
BERGER, AE
BLOWERS, CL
KUENTZEL, SL
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 114 - 114
[29] DIRECT SYNTHESIS OF THE ANTI-TUMOR AGENT ERYTHRO-ALPHA-AMINO-3-BROMO-4,5-DIHYDROISOXAZOLE-5-ACETIC ACID
HAGEDORN, AA
MILLER, BJ
NAGY, JO
TETRAHEDRON LETTERS, 1980, 21 (03) : 229 - 230
[30] ENHANCED EFFECT OF L-GLUTAMINE ANTAGONIST, L-(ALPHAS,5S)-ALPHA-AMINO-3-CHLORO-4.5-DIHYDRO-5-ISOXAZOLEACETIC ACID (NSC-163501), BY ACINETOBACTER GLUTAMINASE-ASPARAGINASE
HOLCENBERG, JS
LU, P
TANG, E
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 168 - 168

← 1 2 3 4 →